Rank | Gene Set | Z-score |
---|---|---|
1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.43521866 |
2 | urate metabolic process (GO:0046415) | 8.78552230 |
3 | drug transmembrane transport (GO:0006855) | 8.76249288 |
4 | organic cation transport (GO:0015695) | 7.50709107 |
5 | drug transport (GO:0015893) | 7.43230528 |
6 | nephron tubule formation (GO:0072079) | 7.19481350 |
7 | phosphate ion transport (GO:0006817) | 7.09759041 |
8 | lysine metabolic process (GO:0006553) | 7.06326323 |
9 | lysine catabolic process (GO:0006554) | 7.06326323 |
10 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 6.59349784 |
11 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 6.57077516 |
12 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 6.48904777 |
13 | thyroid gland development (GO:0030878) | 6.23741507 |
14 | renal absorption (GO:0070293) | 6.07278903 |
15 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 6.05624719 |
16 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.99623486 |
17 | phosphate ion transmembrane transport (GO:0035435) | 5.97834320 |
18 | excretion (GO:0007588) | 5.97161200 |
19 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.88832995 |
20 | quaternary ammonium group transport (GO:0015697) | 5.85701042 |
21 | negative regulation of metanephros development (GO:0072217) | 5.84621041 |
22 | membrane repolarization during action potential (GO:0086011) | 5.84402528 |
23 | cysteine metabolic process (GO:0006534) | 5.55469666 |
24 | response to mercury ion (GO:0046689) | 5.39540690 |
25 | response to lead ion (GO:0010288) | 5.35277039 |
26 | drug catabolic process (GO:0042737) | 5.30104868 |
27 | metanephric nephron tubule development (GO:0072234) | 5.30027122 |
28 | metanephric tubule development (GO:0072170) | 5.30027122 |
29 | exogenous drug catabolic process (GO:0042738) | 5.28226038 |
30 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 5.14475889 |
31 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.11320804 |
32 | glyoxylate metabolic process (GO:0046487) | 5.07132520 |
33 | toxin transport (GO:1901998) | 5.05458996 |
34 | pattern specification involved in kidney development (GO:0061004) | 5.03191778 |
35 | vitamin D metabolic process (GO:0042359) | 4.98726559 |
36 | sulfate transmembrane transport (GO:1902358) | 4.97527672 |
37 | aspartate family amino acid catabolic process (GO:0009068) | 4.95401976 |
38 | metanephric nephron epithelium development (GO:0072243) | 4.85792233 |
39 | tricarboxylic acid metabolic process (GO:0072350) | 4.75691264 |
40 | glutathione biosynthetic process (GO:0006750) | 4.56998406 |
41 | short-chain fatty acid metabolic process (GO:0046459) | 4.56875622 |
42 | glycoside metabolic process (GO:0016137) | 4.49620930 |
43 | metanephric epithelium development (GO:0072207) | 4.48253734 |
44 | modified amino acid transport (GO:0072337) | 4.45354332 |
45 | branched-chain amino acid metabolic process (GO:0009081) | 4.39232837 |
46 | carnitine transport (GO:0015879) | 4.38465917 |
47 | amino-acid betaine transport (GO:0015838) | 4.38465917 |
48 | valine metabolic process (GO:0006573) | 4.38200117 |
49 | trivalent inorganic anion homeostasis (GO:0072506) | 4.36727167 |
50 | phosphate ion homeostasis (GO:0055062) | 4.36727167 |
51 | sulfate transport (GO:0008272) | 4.33586777 |
52 | nephron tubule development (GO:0072080) | 4.30834008 |
53 | homocysteine metabolic process (GO:0050667) | 4.28462774 |
54 | membrane repolarization (GO:0086009) | 4.15238668 |
55 | cellular modified amino acid catabolic process (GO:0042219) | 4.08876428 |
56 | polyol transport (GO:0015791) | 4.04457532 |
57 | mesonephros development (GO:0001823) | 4.04300020 |
58 | negative regulation of kidney development (GO:0090185) | 4.00745782 |
59 | collecting duct development (GO:0072044) | 4.00717750 |
60 | cardiovascular system development (GO:0072358) | 3.99226272 |
61 | urogenital system development (GO:0001655) | 3.97753950 |
62 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.97044773 |
63 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.95797270 |
64 | positive regulation of hormone metabolic process (GO:0032352) | 3.91027626 |
65 | relaxation of cardiac muscle (GO:0055119) | 3.88218531 |
66 | amino-acid betaine metabolic process (GO:0006577) | 3.80558147 |
67 | renal tubule development (GO:0061326) | 3.80507857 |
68 | oligosaccharide catabolic process (GO:0009313) | 3.74977833 |
69 | potassium ion import (GO:0010107) | 3.74625236 |
70 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.74339340 |
71 | peptide biosynthetic process (GO:0043043) | 3.73684559 |
72 | fructose metabolic process (GO:0006000) | 3.71417023 |
73 | glutamate metabolic process (GO:0006536) | 3.70956320 |
74 | sodium ion export (GO:0071436) | 3.70911466 |
75 | carnitine metabolic process (GO:0009437) | 3.67587967 |
76 | cellular potassium ion homeostasis (GO:0030007) | 3.67105497 |
77 | branched-chain amino acid catabolic process (GO:0009083) | 3.66870510 |
78 | indole-containing compound catabolic process (GO:0042436) | 3.63965854 |
79 | indolalkylamine catabolic process (GO:0046218) | 3.63965854 |
80 | tryptophan catabolic process (GO:0006569) | 3.63965854 |
81 | serine family amino acid catabolic process (GO:0009071) | 3.63490157 |
82 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63374885 |
83 | regulation of stem cell maintenance (GO:2000036) | 3.60816965 |
84 | mesenchymal to epithelial transition (GO:0060231) | 3.60078957 |
85 | aromatic amino acid family catabolic process (GO:0009074) | 3.55562454 |
86 | proline metabolic process (GO:0006560) | 3.53844759 |
87 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.53480562 |
88 | positive regulation of digestive system process (GO:0060456) | 3.52829686 |
89 | fatty acid beta-oxidation (GO:0006635) | 3.51433853 |
90 | nephron epithelium development (GO:0072009) | 3.45052607 |
91 | nephron tubule morphogenesis (GO:0072078) | 3.45021064 |
92 | nephron epithelium morphogenesis (GO:0072088) | 3.45021064 |
93 | sulfur compound transport (GO:0072348) | 3.44914342 |
94 | response to parathyroid hormone (GO:0071107) | 3.44000286 |
95 | sodium-independent organic anion transport (GO:0043252) | 3.43837175 |
96 | embryonic epithelial tube formation (GO:0001838) | 3.42748871 |
97 | sodium ion transport (GO:0006814) | 3.41430373 |
98 | positive regulation of metanephros development (GO:0072216) | 3.40818662 |
99 | lipid oxidation (GO:0034440) | 3.40476777 |
100 | vitamin transport (GO:0051180) | 3.40368134 |
101 | serine family amino acid metabolic process (GO:0009069) | 3.39746292 |
102 | tryptophan metabolic process (GO:0006568) | 3.39421429 |
103 | cochlea development (GO:0090102) | 3.39379021 |
104 | cellular response to gonadotropin stimulus (GO:0071371) | 3.38524157 |
105 | peptide catabolic process (GO:0043171) | 3.37982202 |
106 | L-phenylalanine metabolic process (GO:0006558) | 3.36702366 |
107 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.36702366 |
108 | fatty acid oxidation (GO:0019395) | 3.36159548 |
109 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.35332242 |
110 | L-phenylalanine catabolic process (GO:0006559) | 3.35332242 |
111 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 3.33255737 |
112 | response to phenylpropanoid (GO:0080184) | 3.29504058 |
113 | response to lipoprotein particle (GO:0055094) | 3.29223674 |
114 | epithelial tube formation (GO:0072175) | 3.26350439 |
115 | potassium ion homeostasis (GO:0055075) | 3.25646387 |
116 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.25484087 |
117 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25312923 |
118 | inositol metabolic process (GO:0006020) | 3.23655041 |
119 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.22337970 |
120 | cellular ketone body metabolic process (GO:0046950) | 3.21569515 |
121 | glutathione metabolic process (GO:0006749) | 3.19848057 |
122 | glutathione derivative metabolic process (GO:1901685) | 3.13929127 |
123 | glutathione derivative biosynthetic process (GO:1901687) | 3.13929127 |
124 | cellular amino acid catabolic process (GO:0009063) | 3.13127818 |
125 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 3.11690230 |
126 | cellular sodium ion homeostasis (GO:0006883) | 3.10604482 |
127 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.06102896 |
128 | sodium ion homeostasis (GO:0055078) | 3.05176399 |
129 | bicarbonate transport (GO:0015701) | 3.04363174 |
130 | acetyl-CoA metabolic process (GO:0006084) | 3.00268012 |
131 | actin filament depolymerization (GO:0030042) | 2.99728310 |
132 | hydrogen peroxide catabolic process (GO:0042744) | 2.99288454 |
133 | alpha-amino acid catabolic process (GO:1901606) | 2.99281406 |
134 | cellular response to vitamin D (GO:0071305) | 2.98958524 |
135 | positive regulation of mesonephros development (GO:0061213) | 2.96115958 |
136 | specification of organ identity (GO:0010092) | 2.94853850 |
137 | indole-containing compound metabolic process (GO:0042430) | 2.93638544 |
138 | negative regulation of hormone metabolic process (GO:0032351) | 2.92596225 |
139 | transepithelial transport (GO:0070633) | 2.89705046 |
140 | regulation of protein localization to cell surface (GO:2000008) | 2.88451753 |
141 | cobalamin metabolic process (GO:0009235) | 2.88356136 |
142 | hyperosmotic salinity response (GO:0042538) | 2.88345162 |
143 | glutamine family amino acid catabolic process (GO:0009065) | 2.87853044 |
144 | response to water (GO:0009415) | 2.87276364 |
145 | fatty acid catabolic process (GO:0009062) | 2.85628766 |
146 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.85056994 |
147 | sulfur amino acid catabolic process (GO:0000098) | 2.84949118 |
148 | L-ascorbic acid metabolic process (GO:0019852) | 2.84720281 |
149 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.84055583 |
150 | regulation of mesonephros development (GO:0061217) | 2.83080677 |
151 | negative regulation of microtubule polymerization (GO:0031115) | 2.82681557 |
152 | renal tubule morphogenesis (GO:0061333) | 2.81975533 |
153 | one-carbon compound transport (GO:0019755) | 2.80781999 |
154 | carboxylic acid catabolic process (GO:0046395) | 2.80745980 |
155 | organic acid catabolic process (GO:0016054) | 2.80745980 |
156 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.79951729 |
157 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.75316470 |
158 | cell communication by electrical coupling (GO:0010644) | 2.75097625 |
159 | flavonoid metabolic process (GO:0009812) | 2.66404313 |
160 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.65335945 |
161 | inorganic anion transport (GO:0015698) | 2.64346782 |
162 | phenol-containing compound metabolic process (GO:0018958) | 2.63721687 |
163 | cell volume homeostasis (GO:0006884) | 2.60137068 |
164 | cellular anion homeostasis (GO:0030002) | 2.59349239 |
165 | regulation of metanephros development (GO:0072215) | 2.58529267 |
166 | axonemal dynein complex assembly (GO:0070286) | 2.57400639 |
167 | chloride transmembrane transport (GO:1902476) | 2.55963038 |
168 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.51560522 |
169 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.47356765 |
170 | positive regulation of glycogen metabolic process (GO:0070875) | 2.43769994 |
171 | thymus development (GO:0048538) | 2.42972658 |
172 | thyroid hormone generation (GO:0006590) | 13.7540818 |
173 | thyroid hormone metabolic process (GO:0042403) | 11.4020532 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.83764356 |
2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.68090036 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.66655714 |
4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.40636598 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36929757 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20999810 |
7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.06237214 |
8 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.03548285 |
9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00848898 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.91079773 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.88747772 |
12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84475856 |
13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83392093 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.80467812 |
15 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.77701942 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76922271 |
17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76606538 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74845721 |
19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70122483 |
20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.69476694 |
21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.69476694 |
22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63740065 |
23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63225952 |
24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57825776 |
25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55235661 |
26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54065857 |
27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53779446 |
28 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53499579 |
29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.52839100 |
30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51765493 |
31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.50443490 |
32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49297683 |
33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49029403 |
34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48506203 |
35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48377342 |
36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46121294 |
37 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.45665729 |
38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38980492 |
39 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36204282 |
40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34840828 |
41 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.34626153 |
42 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32975224 |
43 | * RXR_22108803_ChIP-Seq_LS180_Human | 1.32025942 |
44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31572804 |
45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31511897 |
46 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31013553 |
47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30577961 |
48 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29249965 |
49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.28919826 |
50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28666360 |
51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27728217 |
52 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.26574267 |
53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.25151767 |
54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24838982 |
55 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23006028 |
56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22734071 |
57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20755652 |
58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20583628 |
59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20149281 |
60 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.19889993 |
61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18318865 |
62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17545252 |
63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17499573 |
64 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17147486 |
65 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.16220926 |
66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16190028 |
67 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.16018710 |
68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15851158 |
69 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15458315 |
70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14888698 |
71 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.13849914 |
72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11786897 |
73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11248230 |
74 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09190957 |
75 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08911608 |
76 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07969103 |
77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06779333 |
78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06652401 |
79 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05723136 |
80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05390985 |
81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05019362 |
82 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.03296509 |
83 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02930488 |
84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02764255 |
85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02595757 |
86 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02580786 |
87 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02507026 |
88 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02065363 |
89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01976537 |
90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01931396 |
91 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01811089 |
92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01771640 |
93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01005626 |
94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00744638 |
95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99785005 |
96 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99544571 |
97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99219831 |
98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98714354 |
99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98581417 |
100 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98419991 |
101 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97817671 |
102 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97313710 |
103 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.95482277 |
104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95231196 |
105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94654833 |
106 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94345569 |
107 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93741223 |
108 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93677955 |
109 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93581420 |
110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93463035 |
111 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.93347479 |
112 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92705952 |
113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91685105 |
114 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91504129 |
115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91278265 |
116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90853409 |
117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90853409 |
118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89880428 |
119 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89094215 |
120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88840701 |
121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87845014 |
122 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87304507 |
123 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87279030 |
124 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84439976 |
125 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84157482 |
126 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84108279 |
127 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.83822326 |
128 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83797917 |
129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83610539 |
130 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83538829 |
131 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.82719355 |
132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82685705 |
133 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82670348 |
134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82456614 |
135 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.81869747 |
136 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.80469050 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004043_abnormal_pH_regulation | 7.09361453 |
2 | MP0005360_urolithiasis | 6.15597017 |
3 | MP0004019_abnormal_vitamin_homeostasis | 4.60866599 |
4 | MP0005332_abnormal_amino_acid | 4.58634490 |
5 | MP0000681_abnormal_thyroid_gland | 4.53815787 |
6 | MP0003878_abnormal_ear_physiology | 4.32961358 |
7 | MP0005377_hearing/vestibular/ear_phenot | 4.32961358 |
8 | MP0003195_calcinosis | 3.66148336 |
9 | MP0001765_abnormal_ion_homeostasis | 3.63587705 |
10 | MP0009643_abnormal_urine_homeostasis | 3.53055035 |
11 | MP0002139_abnormal_hepatobiliary_system | 3.44869059 |
12 | MP0002138_abnormal_hepatobiliary_system | 3.42049422 |
13 | MP0001756_abnormal_urination | 3.15030918 |
14 | MP0001958_emphysema | 2.95481926 |
15 | MP0004885_abnormal_endolymph | 2.90546959 |
16 | MP0005636_abnormal_mineral_homeostasis | 2.78511896 |
17 | MP0002136_abnormal_kidney_physiology | 2.75377465 |
18 | MP0002909_abnormal_adrenal_gland | 2.68563714 |
19 | MP0000383_abnormal_hair_follicle | 2.60445525 |
20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36204885 |
21 | MP0000516_abnormal_urinary_system | 2.17342639 |
22 | MP0005367_renal/urinary_system_phenotyp | 2.17342639 |
23 | MP0010678_abnormal_skin_adnexa | 1.97509927 |
24 | MP0003252_abnormal_bile_duct | 1.85172768 |
25 | MP0002938_white_spotting | 1.81306259 |
26 | MP0008961_abnormal_basal_metabolism | 1.77123807 |
27 | MP0001501_abnormal_sleep_pattern | 1.72435748 |
28 | MP0005365_abnormal_bile_salt | 1.67024858 |
29 | MP0005058_abnormal_lysosome_morphology | 1.66584473 |
30 | MP0000538_abnormal_urinary_bladder | 1.66349546 |
31 | MP0002876_abnormal_thyroid_physiology | 1.65181269 |
32 | MP0001270_distended_abdomen | 1.57899277 |
33 | MP0001485_abnormal_pinna_reflex | 1.57305238 |
34 | MP0003938_abnormal_ear_development | 1.52039153 |
35 | MP0003186_abnormal_redox_activity | 1.48098173 |
36 | MP0005085_abnormal_gallbladder_physiolo | 1.42193001 |
37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39571458 |
38 | MP0002168_other_aberrant_phenotype | 1.28817905 |
39 | MP0003300_gastrointestinal_ulcer | 1.24593873 |
40 | MP0004858_abnormal_nervous_system | 1.22345654 |
41 | MP0002089_abnormal_postnatal_growth/wei | 1.18109710 |
42 | MP0000230_abnormal_systemic_arterial | 1.15420403 |
43 | MP0005670_abnormal_white_adipose | 1.13258272 |
44 | MP0002928_abnormal_bile_duct | 1.09205439 |
45 | MP0005084_abnormal_gallbladder_morpholo | 1.07317228 |
46 | MP0008569_lethality_at_weaning | 1.06796816 |
47 | MP0005535_abnormal_body_temperature | 1.03782082 |
48 | MP0003690_abnormal_glial_cell | 1.03486493 |
49 | MP0009250_abnormal_appendicular_skeleto | 0.98499321 |
50 | MP0003879_abnormal_hair_cell | 0.97079092 |
51 | MP0005451_abnormal_body_composition | 0.94322154 |
52 | MP0001963_abnormal_hearing_physiology | 0.94293937 |
53 | MP0000631_abnormal_neuroendocrine_gland | 0.93083873 |
54 | MP0002135_abnormal_kidney_morphology | 0.92224666 |
55 | MP0004742_abnormal_vestibular_system | 0.91922068 |
56 | MP0002653_abnormal_ependyma_morphology | 0.91435615 |
57 | MP0005319_abnormal_enzyme/_coenzyme | 0.90982883 |
58 | MP0001984_abnormal_olfaction | 0.90242582 |
59 | MP0005666_abnormal_adipose_tissue | 0.86648676 |
60 | MP0002896_abnormal_bone_mineralization | 0.82948345 |
61 | MP0005220_abnormal_exocrine_pancreas | 0.82937476 |
62 | MP0003638_abnormal_response/metabolism_ | 0.81883555 |
63 | MP0005167_abnormal_blood-brain_barrier | 0.80512209 |
64 | MP0008872_abnormal_physiological_respon | 0.79940294 |
65 | MP0009046_muscle_twitch | 0.79623011 |
66 | MP0003646_muscle_fatigue | 0.79319809 |
67 | MP0003183_abnormal_peptide_metabolism | 0.78438168 |
68 | MP0009764_decreased_sensitivity_to | 0.77422085 |
69 | MP0009780_abnormal_chondrocyte_physiolo | 0.77176903 |
70 | MP0004147_increased_porphyrin_level | 0.76570908 |
71 | MP0005165_increased_susceptibility_to | 0.76340469 |
72 | MP0000678_abnormal_parathyroid_gland | 0.76091589 |
73 | MP0003329_amyloid_beta_deposits | 0.74817192 |
74 | MP0002064_seizures | 0.73247754 |
75 | MP0003283_abnormal_digestive_organ | 0.72987125 |
76 | MP0003633_abnormal_nervous_system | 0.72507724 |
77 | MP0004133_heterotaxia | 0.72497818 |
78 | MP0010386_abnormal_urinary_bladder | 0.72116229 |
79 | MP0003172_abnormal_lysosome_physiology | 0.71664323 |
80 | MP0000026_abnormal_inner_ear | 0.71496988 |
81 | MP0001177_atelectasis | 0.69231433 |
82 | MP0002118_abnormal_lipid_homeostasis | 0.68131808 |
83 | MP0001486_abnormal_startle_reflex | 0.67739772 |
84 | MP0005508_abnormal_skeleton_morphology | 0.65830757 |
85 | MP0004270_analgesia | 0.65720079 |
86 | MP0001664_abnormal_digestion | 0.65604531 |
87 | MP0003136_yellow_coat_color | 0.65344717 |
88 | MP0001440_abnormal_grooming_behavior | 0.64843528 |
89 | MP0002067_abnormal_sensory_capabilities | 0.64098965 |
90 | MP0001666_abnormal_nutrient_absorption | 0.64054292 |
91 | MP0006036_abnormal_mitochondrial_physio | 0.63761413 |
92 | MP0002638_abnormal_pupillary_reflex | 0.63282597 |
93 | MP0000778_abnormal_nervous_system | 0.62585725 |
94 | MP0004215_abnormal_myocardial_fiber | 0.62555590 |
95 | MP0000566_synostosis | 0.61404179 |
96 | MP0009384_cardiac_valve_regurgitation | 0.60991366 |
97 | MP0008004_abnormal_stomach_pH | 0.60329810 |
98 | MP0001502_abnormal_circadian_rhythm | 0.58882254 |
99 | MP0005423_abnormal_somatic_nervous | 0.58504701 |
100 | MP0009745_abnormal_behavioral_response | 0.57324341 |
101 | MP0002108_abnormal_muscle_morphology | 0.56778514 |
102 | MP0002735_abnormal_chemical_nociception | 0.56720101 |
103 | MP0001764_abnormal_homeostasis | 0.56581950 |
104 | MP0003075_altered_response_to | 0.56492033 |
105 | MP0005646_abnormal_pituitary_gland | 0.56392210 |
106 | MP0000163_abnormal_cartilage_morphology | 0.56057571 |
107 | MP0005395_other_phenotype | 0.55717472 |
108 | MP0001944_abnormal_pancreas_morphology | 0.55656975 |
109 | MP0009642_abnormal_blood_homeostasis | 0.55415901 |
110 | MP0003941_abnormal_skin_development | 0.54667962 |
111 | MP0002069_abnormal_eating/drinking_beha | 0.54102227 |
112 | MP0002249_abnormal_larynx_morphology | 0.54093099 |
113 | MP0001968_abnormal_touch/_nociception | 0.52877851 |
114 | MP0003045_fibrosis | 0.52435275 |
115 | MP0002572_abnormal_emotion/affect_behav | 0.52362216 |
116 | MP0000462_abnormal_digestive_system | 0.51929278 |
117 | MP0002796_impaired_skin_barrier | 0.50480688 |
118 | MP0000920_abnormal_myelination | 0.50365699 |
119 | MP0002932_abnormal_joint_morphology | 0.50245415 |
120 | MP0002272_abnormal_nervous_system | 0.49846111 |
121 | MP0002736_abnormal_nociception_after | 0.48866492 |
122 | MP0001661_extended_life_span | 0.48508576 |
123 | MP0002115_abnormal_skeleton_extremities | 0.47868978 |
124 | MP0002734_abnormal_mechanical_nocicepti | 0.47834845 |
125 | MP0004134_abnormal_chest_morphology | 0.47772385 |
126 | MP0003953_abnormal_hormone_level | 0.46977998 |
127 | MP0000534_abnormal_ureter_morphology | 0.46265956 |
128 | MP0004484_altered_response_of | 0.45904326 |
129 | MP0002063_abnormal_learning/memory/cond | 0.45610673 |
130 | MP0005595_abnormal_vascular_smooth | 0.45498018 |
131 | MP0001731_abnormal_postnatal_growth | 0.44865774 |
132 | MP0002998_abnormal_bone_remodeling | 0.44373171 |
133 | MP0000049_abnormal_middle_ear | 0.43865721 |
134 | MP0002229_neurodegeneration | 0.43509948 |
135 | MP0002116_abnormal_craniofacial_bone | 0.43097650 |
136 | MP0003631_nervous_system_phenotype | 0.42972536 |
137 | MP0006276_abnormal_autonomic_nervous | 0.42451434 |
138 | MP0003191_abnormal_cellular_cholesterol | 0.41805854 |
139 | MP0004859_abnormal_synaptic_plasticity | 0.41784018 |
140 | MP0003943_abnormal_hepatobiliary_system | 0.41744320 |
141 | MP0003634_abnormal_glial_cell | 0.41415491 |
142 | MP0003942_abnormal_urinary_system | 0.41293447 |
143 | MP0004264_abnormal_extraembryonic_tissu | 0.41185873 |
144 | MP0010329_abnormal_lipoprotein_level | 0.41180184 |
145 | MP0005503_abnormal_tendon_morphology | 0.40731329 |
146 | MP0009703_decreased_birth_body | 0.39994958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased circulating renin level (HP:0000848) | 8.75632660 |
2 | Metabolic alkalosis (HP:0200114) | 8.33302674 |
3 | Hypokalemic alkalosis (HP:0001949) | 8.11743610 |
4 | Hypomagnesemia (HP:0002917) | 7.59552275 |
5 | Hyperactive renin-angiotensin system (HP:0000841) | 7.43795815 |
6 | Polyuria (HP:0000103) | 7.14980045 |
7 | Abnormal urine output (HP:0012590) | 6.84954103 |
8 | Thyroid-stimulating hormone excess (HP:0002925) | 6.56945276 |
9 | Abnormality of chloride homeostasis (HP:0011422) | 6.53481789 |
10 | Abnormality of renal excretion (HP:0011036) | 6.47709773 |
11 | Abnormality of magnesium homeostasis (HP:0004921) | 6.37800966 |
12 | Gout (HP:0001997) | 6.24606795 |
13 | Goiter (HP:0000853) | 6.12350829 |
14 | Abnormal drinking behavior (HP:0030082) | 5.98514914 |
15 | Polydipsia (HP:0001959) | 5.98514914 |
16 | Hyperaldosteronism (HP:0000859) | 5.47118355 |
17 | Hyperphosphatemia (HP:0002905) | 5.43963230 |
18 | Tetany (HP:0001281) | 5.43511685 |
19 | Abnormality of renin-angiotensin system (HP:0000847) | 5.33714303 |
20 | Renal salt wasting (HP:0000127) | 5.30837945 |
21 | Alkalosis (HP:0001948) | 5.01533193 |
22 | Proximal tubulopathy (HP:0000114) | 4.75282681 |
23 | Hyperuricemia (HP:0002149) | 4.52025420 |
24 | Increased purine levels (HP:0004368) | 4.52025420 |
25 | Hyperglycinuria (HP:0003108) | 4.30705747 |
26 | Hypercalciuria (HP:0002150) | 4.06834530 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04842067 |
28 | Hypokalemia (HP:0002900) | 4.02427093 |
29 | Renal tubular acidosis (HP:0001947) | 3.89641115 |
30 | Abnormality of purine metabolism (HP:0004352) | 3.84635483 |
31 | Congenital sensorineural hearing impairment (HP:0008527) | 3.60510262 |
32 | Abnormality of glycine metabolism (HP:0010895) | 3.48844214 |
33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.48844214 |
34 | Abnormality of potassium homeostasis (HP:0011042) | 3.34027100 |
35 | Hypothermia (HP:0002045) | 3.31382461 |
36 | Ketoacidosis (HP:0001993) | 3.28716920 |
37 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 3.25764340 |
38 | Generalized aminoaciduria (HP:0002909) | 3.23431796 |
39 | Abnormality of urine glucose concentration (HP:0011016) | 3.13382739 |
40 | Glycosuria (HP:0003076) | 3.13382739 |
41 | Alacrima (HP:0000522) | 3.03202795 |
42 | Nephrocalcinosis (HP:0000121) | 3.02161413 |
43 | Abnormality of cochlea (HP:0000375) | 2.91783789 |
44 | Hydroxyprolinuria (HP:0003080) | 2.84407089 |
45 | Abnormality of proline metabolism (HP:0010907) | 2.84407089 |
46 | Hyperphosphaturia (HP:0003109) | 2.78337839 |
47 | Hyperthyroidism (HP:0000836) | 2.75523996 |
48 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.73401263 |
49 | Confusion (HP:0001289) | 2.72893910 |
50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.68274794 |
51 | Abnormal urine phosphate concentration (HP:0012599) | 2.66916058 |
52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.62607128 |
53 | Ketosis (HP:0001946) | 2.61820759 |
54 | Potter facies (HP:0002009) | 2.57620033 |
55 | Facial shape deformation (HP:0011334) | 2.57620033 |
56 | Delayed epiphyseal ossification (HP:0002663) | 2.55601083 |
57 | Dehydration (HP:0001944) | 2.52669780 |
58 | Abnormality of sodium homeostasis (HP:0010931) | 2.49173381 |
59 | Hypoparathyroidism (HP:0000829) | 2.48958344 |
60 | Adrenal overactivity (HP:0002717) | 2.48349074 |
61 | Widely patent fontanelles and sutures (HP:0004492) | 2.47313228 |
62 | Decreased lacrimation (HP:0000633) | 2.43058320 |
63 | Vascular calcification (HP:0004934) | 2.42228531 |
64 | Pili torti (HP:0003777) | 2.40981535 |
65 | Vacuolated lymphocytes (HP:0001922) | 2.40821464 |
66 | Nephrolithiasis (HP:0000787) | 2.39728486 |
67 | Thyroid carcinoma (HP:0002890) | 2.39542688 |
68 | Hyperglycinemia (HP:0002154) | 2.37425862 |
69 | Renal tubular dysfunction (HP:0000124) | 2.36200291 |
70 | Delayed CNS myelination (HP:0002188) | 2.36018980 |
71 | Small epiphyses (HP:0010585) | 2.31854156 |
72 | Hyponatremia (HP:0002902) | 2.31239181 |
73 | Morphological abnormality of the inner ear (HP:0011390) | 2.29445032 |
74 | Hypophosphatemia (HP:0002148) | 2.23116710 |
75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22842695 |
76 | Intellectual disability, moderate (HP:0002342) | 2.21589541 |
77 | Tubular atrophy (HP:0000092) | 2.19497875 |
78 | Abnormality of renal resorption (HP:0011038) | 2.15532884 |
79 | Tubulointerstitial fibrosis (HP:0005576) | 2.15079138 |
80 | Enlarged kidneys (HP:0000105) | 2.13317193 |
81 | Microretrognathia (HP:0000308) | 2.12564375 |
82 | Rickets (HP:0002748) | 2.12499487 |
83 | Cardiovascular calcification (HP:0011915) | 2.11328671 |
84 | Hyperparathyroidism (HP:0000843) | 2.07266680 |
85 | Nasolacrimal duct obstruction (HP:0000579) | 2.02944506 |
86 | Mixed hearing impairment (HP:0000410) | 2.01402375 |
87 | Hyperammonemia (HP:0001987) | 1.98704999 |
88 | Vomiting (HP:0002013) | 1.97259118 |
89 | Large eyes (HP:0001090) | 1.97199938 |
90 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.96947671 |
91 | Decreased circulating renin level (HP:0003351) | 1.96033685 |
92 | Abnormal eating behavior (HP:0100738) | 1.94220813 |
93 | Chondrocalcinosis (HP:0000934) | 1.92705799 |
94 | Hypothyroidism (HP:0000821) | 1.91771175 |
95 | Hypocalcemia (HP:0002901) | 1.86677004 |
96 | Abnormality of Sharpey fibers (HP:0100685) | 1.84157790 |
97 | Metabolic acidosis (HP:0001942) | 1.82977199 |
98 | Methylmalonic aciduria (HP:0012120) | 1.82560583 |
99 | Abnormal ciliary motility (HP:0012262) | 1.80933938 |
100 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79962171 |
101 | Absent/shortened dynein arms (HP:0200106) | 1.79962171 |
102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78038113 |
103 | Dicarboxylic aciduria (HP:0003215) | 1.78038113 |
104 | Hypotension (HP:0002615) | 1.77703471 |
105 | Hyperpituitarism (HP:0010514) | 1.75221133 |
106 | Abnormality of the renal medulla (HP:0100957) | 1.74397085 |
107 | Abnormality of the lacrimal duct (HP:0011481) | 1.71485634 |
108 | Malnutrition (HP:0004395) | 1.71014250 |
109 | Metaphyseal cupping (HP:0003021) | 1.70945528 |
110 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.67173439 |
111 | Abnormality of the dental root (HP:0006486) | 1.66389161 |
112 | Taurodontia (HP:0000679) | 1.66389161 |
113 | Abnormality of permanent molar morphology (HP:0011071) | 1.66389161 |
114 | Lethargy (HP:0001254) | 1.66206993 |
115 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.66032090 |
116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64523049 |
117 | Sensorimotor neuropathy (HP:0007141) | 1.64348391 |
118 | Polyphagia (HP:0002591) | 1.62746564 |
119 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.61301073 |
120 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.61301073 |
121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.60633683 |
122 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.59463751 |
123 | Generalized muscle weakness (HP:0003324) | 1.59282135 |
124 | Focal segmental glomerulosclerosis (HP:0000097) | 1.58785865 |
125 | Abnormality of the dental pulp (HP:0006479) | 1.58684723 |
126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.58312651 |
127 | Glomerulosclerosis (HP:0000096) | 1.57419336 |
128 | Bicornuate uterus (HP:0000813) | 1.56740529 |
129 | Pancreatic cysts (HP:0001737) | 1.55908629 |
130 | Preauricular pit (HP:0004467) | 1.55621651 |
131 | Periauricular skin pits (HP:0100277) | 1.55621651 |
132 | Nephrogenic diabetes insipidus (HP:0009806) | 1.54905167 |
133 | Constipation (HP:0002019) | 1.54742513 |
134 | Metaphyseal irregularity (HP:0003025) | 1.53909832 |
135 | Tubulointerstitial abnormality (HP:0001969) | 1.53184009 |
136 | Abnormality of molar (HP:0011077) | 1.52946651 |
137 | Abnormality of molar morphology (HP:0011070) | 1.52946651 |
138 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.52211180 |
139 | Thin bony cortex (HP:0002753) | 1.51210205 |
140 | Hyperkalemia (HP:0002153) | 1.49517404 |
141 | Tachypnea (HP:0002789) | 1.48290308 |
142 | Abnormality of the nasolacrimal system (HP:0000614) | 1.46897290 |
143 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.46556624 |
144 | Abnormality of the renal cortex (HP:0011035) | 1.46459604 |
145 | Coarse facial features (HP:0000280) | 1.45888916 |
146 | Abnormality of the costochondral junction (HP:0000919) | 1.45834924 |
147 | Hyperventilation (HP:0002883) | 1.44729979 |
148 | Dysostosis multiplex (HP:0000943) | 1.43100087 |
149 | Abnormality of macular pigmentation (HP:0008002) | 1.37325455 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 8.05035074 |
2 | WNK3 | 7.92850489 |
3 | OXSR1 | 7.15262264 |
4 | STK39 | 4.12833274 |
5 | SGK223 | 2.51705350 |
6 | SGK494 | 2.51705350 |
7 | STK38L | 2.29190388 |
8 | SGK2 | 2.07549397 |
9 | WNK1 | 2.00536341 |
10 | AKT3 | 1.90973708 |
11 | BCKDK | 1.89331883 |
12 | PNCK | 1.86212360 |
13 | SGK3 | 1.79364277 |
14 | MST4 | 1.51510029 |
15 | STK38 | 1.49060117 |
16 | PDK2 | 1.48848824 |
17 | EPHA2 | 1.39479602 |
18 | PDK4 | 1.33390224 |
19 | PDK3 | 1.33390224 |
20 | MST1R | 1.29428369 |
21 | FRK | 1.25976618 |
22 | MAP3K12 | 1.07742774 |
23 | NEK1 | 1.04863625 |
24 | PINK1 | 0.96818653 |
25 | MUSK | 0.96067084 |
26 | RET | 0.91240641 |
27 | EPHA4 | 0.82561009 |
28 | SGK1 | 0.80896908 |
29 | EPHB1 | 0.79007694 |
30 | MAPK15 | 0.78597026 |
31 | BMPR1B | 0.76406561 |
32 | NTRK2 | 0.75785224 |
33 | INSRR | 0.74495842 |
34 | FGFR4 | 0.72662188 |
35 | GRK1 | 0.69803314 |
36 | ADRBK2 | 0.65023093 |
37 | GSK3A | 0.63966462 |
38 | NLK | 0.62145565 |
39 | ERBB2 | 0.61655614 |
40 | RIPK1 | 0.61579898 |
41 | LATS1 | 0.60316660 |
42 | CASK | 0.59909944 |
43 | DAPK2 | 0.59003596 |
44 | IRAK1 | 0.57632223 |
45 | IRAK3 | 0.57527557 |
46 | MAP3K7 | 0.54588114 |
47 | FER | 0.54248645 |
48 | IRAK2 | 0.51803552 |
49 | MAP3K2 | 0.51783491 |
50 | NTRK1 | 0.49971967 |
51 | TIE1 | 0.49942435 |
52 | LRRK2 | 0.49867920 |
53 | TNK2 | 0.49307911 |
54 | MINK1 | 0.48968359 |
55 | PRKAA1 | 0.47906947 |
56 | DDR2 | 0.46934648 |
57 | NEK6 | 0.46620012 |
58 | MYLK | 0.46302465 |
59 | PRKD3 | 0.46083004 |
60 | SIK3 | 0.44483215 |
61 | PDPK1 | 0.44175589 |
62 | SIK1 | 0.43595051 |
63 | PAK3 | 0.42818595 |
64 | PRKAA2 | 0.42280963 |
65 | NTRK3 | 0.39565989 |
66 | PASK | 0.39021134 |
67 | PHKG2 | 0.38664763 |
68 | PHKG1 | 0.38664763 |
69 | LMTK2 | 0.38421874 |
70 | ERBB4 | 0.38214749 |
71 | MAP2K7 | 0.38182740 |
72 | MAP3K3 | 0.37133632 |
73 | PRKCZ | 0.36348102 |
74 | PTK6 | 0.35999381 |
75 | MAP2K2 | 0.35884231 |
76 | GRK6 | 0.35733952 |
77 | MAPK13 | 0.34465940 |
78 | CSNK1A1L | 0.33266759 |
79 | MAP2K6 | 0.32554439 |
80 | PRKD2 | 0.32546554 |
81 | TNIK | 0.32226497 |
82 | PRKCG | 0.31074921 |
83 | MAPK7 | 0.30999070 |
84 | STK3 | 0.30503647 |
85 | MAP2K1 | 0.29803029 |
86 | PKN1 | 0.29723452 |
87 | PRKCE | 0.29228422 |
88 | PRKCH | 0.28211020 |
89 | MAPK12 | 0.27607550 |
90 | PRKCA | 0.27295478 |
91 | PTK2 | 0.27118950 |
92 | STK24 | 0.26860576 |
93 | CSNK1G2 | 0.26804332 |
94 | PRKCD | 0.25555130 |
95 | MAP4K2 | 0.25483925 |
96 | PDK1 | 0.24347561 |
97 | TRIB3 | 0.24326441 |
98 | STK11 | 0.24174237 |
99 | FGFR2 | 0.23722713 |
100 | ROCK1 | 0.23595558 |
101 | CAMK1G | 0.23246949 |
102 | PRKACA | 0.22082308 |
103 | DMPK | 0.22019394 |
104 | PRKACG | 0.21975850 |
105 | PAK6 | 0.21839519 |
106 | MARK1 | 0.21285976 |
107 | MAPK11 | 0.21087754 |
108 | CAMKK2 | 0.20930173 |
109 | CDK5 | 0.20843059 |
110 | MAP2K4 | 0.20479876 |
111 | BCR | 0.20439258 |
112 | EPHB2 | 0.19308761 |
113 | TGFBR2 | 0.18070063 |
114 | MAPKAPK3 | 0.17666671 |
115 | PRKG2 | 0.17651568 |
116 | MAP3K14 | 0.17296330 |
117 | ERBB3 | 0.16906587 |
118 | EPHA3 | 0.16523815 |
119 | PRKCI | 0.16052595 |
120 | ABL2 | 0.15926706 |
121 | PIK3CA | 0.15896310 |
122 | CSNK1A1 | 0.15030483 |
123 | FGFR3 | 0.15007917 |
124 | TRPM7 | 0.14914638 |
125 | MAP3K4 | 0.14465242 |
126 | SIK2 | 0.13731938 |
127 | AKT2 | 0.13619938 |
128 | TYRO3 | 0.12937050 |
129 | ADRBK1 | 0.12824946 |
130 | SRC | 0.12316227 |
131 | IGF1R | 0.12268943 |
132 | DYRK1A | 0.11748164 |
133 | RPS6KA3 | 0.11676427 |
134 | MET | 0.11360340 |
135 | PRKCQ | 0.11335833 |
136 | ROCK2 | 0.11242169 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 4.27895950 |
2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.31119165 |
3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.14080683 |
4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.99360249 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82901979 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.71924506 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.61978635 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59843998 |
9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.50840233 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40975934 |
11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.40714699 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38620656 |
13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.36597507 |
14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29451309 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.26819985 |
16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.16771873 |
17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.01871173 |
18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.94803727 |
19 | Bile secretion_Homo sapiens_hsa04976 | 1.94431932 |
20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87775618 |
21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85971626 |
22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85281982 |
23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81155517 |
24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.74026904 |
25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73689503 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70923913 |
27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69423492 |
28 | Mineral absorption_Homo sapiens_hsa04978 | 1.62175052 |
29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56758661 |
30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46958738 |
31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.44223898 |
32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37321804 |
33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34102338 |
34 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.31191438 |
35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.27316263 |
36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25167940 |
37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19551378 |
38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15481713 |
39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.12243388 |
40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.10182825 |
41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10097388 |
42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05969236 |
43 | Lysine degradation_Homo sapiens_hsa00310 | 1.02479542 |
44 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.01916852 |
45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92606620 |
46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88896336 |
47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86388733 |
48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85432938 |
49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84259747 |
50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82456956 |
51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81538251 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81016099 |
53 | Phototransduction_Homo sapiens_hsa04744 | 0.77897311 |
54 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75723295 |
55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74413842 |
56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73622848 |
57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73555114 |
58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71960085 |
59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71511599 |
60 | Lysosome_Homo sapiens_hsa04142 | 0.69039036 |
61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68998527 |
62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68696970 |
63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67967450 |
64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66229827 |
65 | Morphine addiction_Homo sapiens_hsa05032 | 0.65936506 |
66 | Tight junction_Homo sapiens_hsa04530 | 0.65735617 |
67 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65617560 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65380775 |
69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65106188 |
70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63336632 |
71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61852990 |
72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59962412 |
73 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58017798 |
74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57741269 |
75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55682924 |
76 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55572801 |
77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55346418 |
78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55210397 |
79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53211045 |
80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51388786 |
81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51036606 |
82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50596544 |
83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49284494 |
84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48439326 |
85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47048502 |
86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46709023 |
87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46377512 |
88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44756000 |
89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43827367 |
90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43078679 |
91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42412133 |
92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41120406 |
93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40265492 |
94 | Focal adhesion_Homo sapiens_hsa04510 | 0.39877348 |
95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39833440 |
96 | Salivary secretion_Homo sapiens_hsa04970 | 0.38682258 |
97 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.37619693 |
98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37088203 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37010135 |
100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34945191 |
101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34378956 |
102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33731719 |
103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32422957 |
104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31494100 |
105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31436632 |
106 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30994214 |
107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30645645 |
108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30397841 |
109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29955384 |
110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28001744 |
111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27316466 |
112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.27170974 |
113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.25658993 |
114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25516602 |
115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.25001541 |
116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.24760247 |
117 | ABC transporters_Homo sapiens_hsa02010 | 0.23728965 |
118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22196805 |
119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22089422 |
120 | Insulin secretion_Homo sapiens_hsa04911 | 0.21933812 |
121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.18514961 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15547170 |
123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14747328 |
124 | Parkinsons disease_Homo sapiens_hsa05012 | 0.13027053 |
125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12205965 |
126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10666892 |
127 | Taste transduction_Homo sapiens_hsa04742 | 0.10229353 |
128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.08524352 |
129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.07973000 |
130 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.03258450 |
131 | Renin secretion_Homo sapiens_hsa04924 | 0.03229253 |